Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Ovid Therapeutics Inc (OVID)

Ovid Therapeutics Inc (OVID)
0.2835 x 95 0.3000 x 2
Post-market by (Cboe BZX)
0.2886 +0.0177 (+6.53%) 04/17/25 [NASDAQ]
0.2835 x 95 0.3000 x 2
Post-market 0.2980 +0.0094 (+3.26%) 19:28 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.2720
Day High
0.2912
Open 0.2820
Previous Close 0.2709 0.2709
Volume 227,100 227,100
Avg Vol 459,810 459,810
Stochastic %K 29.39% 29.39%
Weighted Alpha -81.05 -81.05
5-Day Change +0.0336 (+13.18%) +0.0336 (+13.18%)
52-Week Range 0.2425 - 3.4500 0.2425 - 3.4500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,512
  • Shares Outstanding, K 71,075
  • Annual Sales, $ 570 K
  • Annual Income, $ -26,430 K
  • EBIT $ -62 M
  • EBITDA $ -61 M
  • 60-Month Beta 0.44
  • Price/Sales 34.02
  • Price/Cash Flow N/A
  • Price/Book 0.28
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.38
  • Most Recent Earnings $-0.13 on 03/11/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 757.67% ( +142.16%)
  • Historical Volatility 105.39%
  • IV Percentile 96%
  • IV Rank 79.39%
  • IV High 930.51% on 02/28/25
  • IV Low 91.73% on 05/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 936
  • Open Int (30-Day) 942

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.14
  • Number of Estimates 4
  • High Estimate -0.13
  • Low Estimate -0.15
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +17.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2425 +19.01%
on 04/09/25
Period Open: 0.4661
0.4857 -40.58%
on 03/20/25
-0.1775 (-38.08%)
since 03/17/25
3-Month
0.2425 +19.01%
on 04/09/25
Period Open: 0.7400
0.8079 -64.28%
on 01/29/25
-0.4514 (-61.00%)
since 01/17/25
52-Week
0.2425 +19.01%
on 04/09/25
Period Open: 3.1100
3.4500 -91.63%
on 04/30/24
-2.8214 (-90.72%)
since 04/17/24

Most Recent Stories

More News
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

OVID : 0.2886 (+6.53%)
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

OVID : 0.2886 (+6.53%)
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

OVID : 0.2886 (+6.53%)
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

OVID : 0.2886 (+6.53%)
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

OVID : 0.2886 (+6.53%)
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

OVID : 0.2886 (+6.53%)
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

OVID : 0.2886 (+6.53%)
Ovid Therapeutics to Host Investor Event

OVID : 0.2886 (+6.53%)
3 'Strong Buy'-Rated Stocks to Buy Now on the Dip

These outstanding growth stocks are worth buying on the dip.

$SPX : 5,282.70 (unch)
OVID : 0.2886 (+6.53%)
GEHC : 62.37 (+1.45%)
GD : 276.08 (-0.20%)
AMZN : 172.61 (-0.99%)
TAK : 14.71 (+0.41%)
Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

Anticipates filing an Investigational New Drug application for OV329, a potent GABA-aminotransferase inhibitor, and initiating a Phase 1 trial in the...

OVID : 0.2886 (+6.53%)
Dollar Gains on US Economic News and Hawkish Bostic

The dollar index (DXY00 ) Tuesday rose by +0.53%. The dollar Tuesday rose moderately on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Dollar Edges Higher on Strength in US Economic News

The dollar index (DXY00 ) today is up by +0.42%. The dollar today is moderately higher on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Is The Most Crowded Trade a Bubble? – Gold Outflows

Phil Streible dives into the shift in sentiment around gold as outflows begin to emerge. Is this a healthy pullback—or a sign of something bigger? Tune in to today’s Metals Minute for the full breakdown....

Tariff Worries Weigh on the Dollar

The dollar index (DXY00 ) Monday fell by -0.49% and is just above last Friday’s 3-year low. The dollar posted moderate losses Monday as a stock rebound curbed liquidity demand for the dollar. The dollar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Barrick Gold (GOLD) Has Attracted Both Unusual and Mispriced Option Behaviors

With fear brewing in the atmosphere, an investment in GOLD stock makes sense—and on a tangible discount as well.

GOLD : 20.17 (-2.32%)
Gold, Silver, Stocks, Copper: New Situation & New Opportunities

So, Trump backed off a little, while China discretely flexed its muscles by halting exports of its rare earth minerals.

Goldman $3700 Year-end Target - What about Silver?

Phil Streible breaks down Goldman Sachs’ bold call on gold and what it could mean for silver’s path forward. Catch the key levels and catalysts in today’s Metals Minute!

Dollar Weakens as Stocks Rebound

The dollar index (DXY00 ) today is down by -0.20% and is just above last Friday's 3-year low. The dollar is posting moderate losses today as a stock rebound has curbed liquidity demand for the dollar....

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Heating Oil butterfly spread and a Gold calendar spread

Heating Oil has been sliding down the trendline for nearly 3 years now.  The candle this past week could be pointing to a bottom.  Given the immense selling in Energy these past few weeks, HO looks primed...

Tariff Angst Sinks the Dollar and Boosts Gold to a Record High

The dollar index (DXY00 ) Friday fell by -0.80% and posted a 3-year low. The dollar retreated Friday because of concerns that the escalation of the US-China trade war would derail the economy and lead...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Dollar Gains on US Economic News and Hawkish Bostic

The dollar index (DXY00 ) Tuesday rose by +0.53%. The dollar Tuesday rose moderately on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Dollar Edges Higher on Strength in US Economic News

The dollar index (DXY00 ) today is up by +0.42%. The dollar today is moderately higher on better-than-expected US economic news on Apr Empire manufacturing survey general business conditions and the Mar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Is The Most Crowded Trade a Bubble? – Gold Outflows

Phil Streible dives into the shift in sentiment around gold as outflows begin to emerge. Is this a healthy pullback—or a sign of something bigger? Tune in to today’s Metals Minute for the full breakdown....

Tariff Worries Weigh on the Dollar

The dollar index (DXY00 ) Monday fell by -0.49% and is just above last Friday’s 3-year low. The dollar posted moderate losses Monday as a stock rebound curbed liquidity demand for the dollar. The dollar...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Barrick Gold (GOLD) Has Attracted Both Unusual and Mispriced Option Behaviors

With fear brewing in the atmosphere, an investment in GOLD stock makes sense—and on a tangible discount as well.

GOLD : 20.17 (-2.32%)
Gold, Silver, Stocks, Copper: New Situation & New Opportunities

So, Trump backed off a little, while China discretely flexed its muscles by halting exports of its rare earth minerals.

Goldman $3700 Year-end Target - What about Silver?

Phil Streible breaks down Goldman Sachs’ bold call on gold and what it could mean for silver’s path forward. Catch the key levels and catalysts in today’s Metals Minute!

Dollar Weakens as Stocks Rebound

The dollar index (DXY00 ) today is down by -0.20% and is just above last Friday's 3-year low. The dollar is posting moderate losses today as a stock rebound has curbed liquidity demand for the dollar....

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)
Heating Oil butterfly spread and a Gold calendar spread

Heating Oil has been sliding down the trendline for nearly 3 years now.  The candle this past week could be pointing to a bottom.  Given the immense selling in Energy these past few weeks, HO looks primed...

Tariff Angst Sinks the Dollar and Boosts Gold to a Record High

The dollar index (DXY00 ) Friday fell by -0.80% and posted a 3-year low. The dollar retreated Friday because of concerns that the escalation of the US-China trade war would derail the economy and lead...

DXY00 : 98.335 (-0.90%)
GCM25 : 3,395.6 (+2.02%)
SIK25 : 32.780 (+0.95%)
^USDJPY : 140.772 (-1.13%)
^EURUSD : 1.15162 (+1.26%)

Business Summary

Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved...

See More

Key Turning Points

3rd Resistance Point 0.3151
2nd Resistance Point 0.3031
1st Resistance Point 0.2959
Last Price 0.2886
1st Support Level 0.2767
2nd Support Level 0.2647
3rd Support Level 0.2575

See More

52-Week High 3.4500
Fibonacci 61.8% 2.2247
Fibonacci 50% 1.8463
Fibonacci 38.2% 1.4678
Last Price 0.2886
52-Week Low 0.2425

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro